References
G.C. Farrell, D. van Rooyen, L. Gan, S. Chitturi, NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Gut Liver 6, 149–171 (2012)
R. Loomba, A.J. Sanyal, The global NAFLD epidemic. Nat. Rev. Gastroenterol. Hepatol. 10, 686–690 (2013)
K.H. Williams, Diabetes and nonalcoholic fatty liver disease: a pathogenic duo. Endocr. Rev. 34, 84–129 (2013)
G. Musso, R. Gambino, M. Cassader, G. Pagano, Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann. Med. 43, 617–649 (2011)
R. Lomonaco, C. Ortiz-Lopez, B. Orsak, A. Webb, J. Hardies, C. Darland, J. Finch, A. Gastaldelli, S. Harrison, F. Tio, K. Cusi, Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 55, 1389–1397 (2012)
I.R. Willner, B. Waters, S.R. Patil, A. Reuben, J. Morelli, C.A. Riely, Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am. J. Gastroenterol. 96, 2957–2961 (2001)
C. Ortiz-Lopez, R. Lomonaco, B. Orsak, J. Finch, Z. Chang, V.G. Kochunov, J. Hardies, K. Cusi, Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). Diabetes Care 35, 873–878 (2012)
G. Targher, M. Chonchol, I. Pichiri, G. Zoppini, Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence?. J. Endocrinol. Invest. 34, 544–555 (2011)
R. Loomba, M. Abraham, A. Unalp, L. Wilson, J. Lavine, E. Doo, N.M. Bass, Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 56, 943–951 (2012)
C.R.A. Lesmana et al. Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study. Diabetes Metab. Syndr. Obes. 8, 213–218 (2015)
S.M. Kramer, A.R. Feinstein, Clinical biostatistics: LIV. The biostatistics of concordance. Clin. Pharmacol. Ther. 29, 111–123 (1981)
K. Shaye, T. Amir, S. Shlomo, S. Yechezkel, Fasting glucose levels within the high normal range predict cardiovascular outcome. Am. Heart. J. 164(1), 111–116 (2012)
F.C. Hsiao, C.H. Hsieh, C.Z. Wu, C.H. Hsu, J.D. Lin, T.I. Lee, D. Pei, Y.L. Chen, Elevated fasting glucose levels within normal range are associated with an increased risk of metabolic syndrome in older women. Eur. J. Intern. Med. 24(5), 425–429 (2013). doi:10.1016/j.ejim.2013.03.013
P. Di Bonito, E. Sanguigno, C. Forziato, F. Saitta, M.R. Iardino, B. Capaldo, Fasting plasma glucose and clustering of cardiometabolic risk factors in normoglycemic outpatient children and adolescents. Diabetes Care 34(6), 1412–1414 (2011). doi:10.2337/dc10-1783
T.V. Fiorentino, M.A. Marini, F. Andreozzi, F. Arturi, E. Succurro, M. Perticone, A. Sciacqua, M.L. Hribal, F. Perticone, G. Sesti, One-hour postload hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose. J. Clin. Endocrinol. Metab. 100(10), 3744–3751 (2015). doi:10.1210/jc.2015-2573
G. Sesti, M.L. Hribal, T.V. Fiorentino, A. Sciacqua, F. Perticone, Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease. Br. Med. J. Open Diabetes Res. Care 2(1), e000016 (2014). doi:10.1136/bmjdrc-2014-000016
G. Sesti, T.V. Fiorentino, E. Succurro, M. Perticone, F. Arturi, A. Sciacqua, F. Perticone, Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile. Acta Diabetol. 51(6), 927–932 (2014). doi:10.1007/s00592-013-0539-x
C.H. Chiang, C.C. Huang, W.L. Chan, J.W. Chen, H.B. Leu, The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population. Clin. Biochem. 43(18), 1399–1404 (2010). doi:10.1016/j.clinbiochem.2010.09.003
M. Foroughi, Z. Maghsoudi, S. Khayyatzadeh, R. Ghiasvand, G. Askari, B. Iraj, Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver. Adv. Biomed. Res. 5, 28 (2016). doi:10.4103/2277-9175.176368
K. Kato, T. Otsuka, N. Kobayashi, Y. Kon, T. Kawada, Two-hour post-load plasma glucose levels are associated with carotid intima-media thickness in subjects with normal glucose tolerance. Diabet. Med. 31(1), 76–83 (2014). doi:10.1111/dme.12288
R. Takahashi, N. Taguchi, M. Suzuki, X.W. Cheng, Y. Numaguchi, H. Tsukamoto, N. Ikeda, T. Murohara, K. Okumura, Cholesterol and triglyceride concentrations in lipoproteins as related to carotid intima-media thickness. Int. Heart J. 53(1), 29–34 (2012)
Author contributions
S.M. and N.P. contributed to the conception and the design of the study. A.C. and T.F. contributed to the acquisition and the collection of data. P.M. performed laboratory assays. N.P. and G.V. performed abdominal ultrasound. L.N. performed the statistical analysis. S.M., N.P., T.F., and L.N. have been involved in the interpretation of data and in drafting the manuscript. A.L. critically revised the manuscript for important intellectual content. All authors approved the version to be submitted.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Pallotta, N., Filardi, T., Carnovale, A. et al. Two-hour postload glycemia is associated to an increased risk of NAFLD in healthy subjects with family history of type 2 diabetes: a case control study. Endocrine 57, 352–355 (2017). https://doi.org/10.1007/s12020-016-1008-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-1008-4